Novo Nordisk’s SOUL trial confirms that oral semaglutide significantly reduces the risk of heart attack, stroke, and ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Trial confirms that oral semaglutide lowers cardiovascular risk in type 2 diabetes, regardless of SGLT2i use. Read more!

Beth Riehle has gone viral for her TikTok "fit checks," which help her practice her speech after having 80% of her tongue ...

The race is on to make the first oral weight loss medicines, but smaller US pharmacies may have already got there – if they can persuade US regulators their products are legal ...

Fact checked by Nick Blackmer Compounded versions of semaglutide, the active ingredient in weight loss drugs like Ozempic and ...

Not only is the skin under your eyes thinner and more delicate than in other areas of your face, it’s also where lymphatic fluid drainage occurs, says dermatologist Dr. Lauren Penzi, MD.

Researchers saw no benefits in terms of weight loss, diabetes remission, or surgery safety when patients received neoadjuvant semaglutide before MBS. HealthDay News — Neoadjuvant semaglutide before ...

Itepekimab is currently under clinical investigation for COPD in two Phase 3 trials and its safety and efficacy have not been evaluated by any regulatory authority. Dupixent is available in Japan in a ...

Copenhagen, DENMARK — Obesity drug giant Novo Nordisk said Thursday that the rampant growth of the U.S.' compounded drug industry was hurting Wegovy sales, and warned it was considering legal ...

Novo Nordisk already has approval for semaglutide under the Wegovy brand for obesity, while Lilly is in the process of seeking approval to add weight loss to the label of Mounjaro. Both drugs are ...